Inventor
Timothy B. Lowinger
Inventor
Carlisle, MA, US
Overview
Patents· 44 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes19%
C07DHeterocyclic compounds17%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds9%
C07KPeptides8%
C08LCompositions of macromolecular compounds7%
C07CAcyclic or carbocyclic compounds6%
A61LMethods or apparatus for sterilising materials or objects in general4%
C12NMicroorganisms or enzymes1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,947,317NaPi2b-targeted antibody-drug conjugates and methods of use thereof202110,772,971Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates202010,660,901Pyrrolobenzodiazepines and conjugates thereof202010,603,386Protein-polymer-drug conjugates202010,537,645Protein-polymer-drug conjugates202010,526,294Pyrrolobenzodiazepines and conjugates thereof202010,316,080Protein-polymer-drug conjugates201910,226,535Auristatin compounds and conjugates thereof201910,143,695Pyrrolobenzodiazepines and conjugates thereof20189,943,609Protein-polymer-drug conjugates20189,849,191Protein-polymer-drug conjugates20179,808,528'Protein-polymer-drug conjugates and methods of using same'20179,770,519'Protein-polymer-drug conjugates'20179,738,720'Monoclonal antibodies against HER2 epitope and methods of use thereof'20179,555,112'Monoclonal antibodies against HER2 epitope and methods of use thereof'20179,254,339'Protein-polymer-drug conjugates'20169,144,615'Protein-polymer-drug conjugates'20158,841,330'Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'20148,821,850'Protein-polymer-drug conjugates'20148,815,226'Protein-polymer-drug conjugates'20148,808,679'Auristatin compounds and conjugates thereof'20148,685,383'Protein-polymer-drug conjugates'20148,524,214'Polyal drug conjugates comprising variable rate-releasing linkers'20138,349,308'Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof'20138,242,118'Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders'20128,124,630'ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'20127,928,239'Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas'20117,897,623'ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors'20117,700,586'Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders'20107,625,915'Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas'20097,528,255'Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors'20097,517,880'Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas'20097,435,743'Pyridine derivatives'20087,410,986'4-6-diphenyl pyridine derivatives as antiinflammatory agents'20087,375,103'Optically active pyridine derivative and a medicament containing the same'20087,351,834'ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'20087,329,670'Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas'20087,235,576'Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'20077,232,909'Pyridine derivatives'20076,984,649'Pyridine derivatives'20066,911,443'Imidazopyrimidine derivatives and triazolopyrimidine derivatives'20056,562,811'Pyridine derivatives'20036,541,468'Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer'20036,013,646'Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2008Patents assigned to BAYER AG (8)· patent assignee history
2000–2014Based in Nishinomiya, JP· patent location history
2005–2009Based in Wuppertal, DE· patent location history
2007–2009Patents assigned to BAYER PHARMACEUTICALS CORP (5)· patent assignee history
2007–2012Based in Guilford, CT, US· patent location history
2008Based in Hyogo, JP· patent location history
2009–2014Patents assigned to BAYER HEALTHCARE LLC (5)· patent assignee history
2011–2021Based in Carlisle, MA, US· patent location history
2012–2014Patents assigned to LOWINGER TIMOTHY B (6)· patent assignee history
2013–2021Patents assigned to MERSANA THERAPEUTICS INC (21)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERSANA THERAPEUTICS INC | 21 | 2013–2021 |
| BAYER AG | 8 | 2000–2008 |
| LOWINGER TIMOTHY Bself | 6 | 2012–2014 |
| BAYER HEALTHCARE LLC | 5 | 2009–2014 |
| BAYER PHARMACEUTICALS CORP | 5 | 2007–2009 |
Locations
| Location | Patents | Span |
|---|---|---|
| Carlisle, Massachusetts, US | 24 | 2011–2021 |
| Nishinomiya, JP | 10 | 2000–2014 |
| Guilford, CT, US | 5 | 2007–2012 |
| Wuppertal, DE | 4 | 2005–2009 |
| Hyogo, JP | 1 | 2008 |